Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
10 studies found for:    esperion
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Placebo
2 Recruiting Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Conditions: Hypercholesterolemia;   Hypertension
Interventions: Drug: ETC-1002;   Drug: Placebo
3 Active, not recruiting Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Ezetimibe
4 Completed A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Placebo
5 Completed A Study of the Efficacy and Safety of ETC-1002 in Subjects With Statin Intolerance
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002 or placebo;   Drug: Placebo
6 Completed A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides
Condition: Dyslipidemia
Interventions: Drug: ETC-1002;   Drug: Placebo
7 Completed Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002
Condition: Hyperlipidemia
Intervention: Drug: [14C-ETC-1002]
8 Completed A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
Condition: Mild Dyslipidemia
Intervention: Drug: ETC-1002 or placebo
9 Completed A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes
Conditions: Hyperlipidemia;   Type 2 Diabetes
Intervention: Drug: ETC-1002 or placebo
10 Completed A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects
Condition: Safety Evaluation of Escalating Doses
Intervention: Drug: ETC-1002

Indicates status has not been verified in more than two years